---
layout: post
title: "复星医药：子公司药品获临床试验批准"
date: 2022-01-18 16:46:07 +0800
categories: emnews
tags: 东财滚动新闻
---
> 复星医药公告，控股子公司复宏汉霖收到国家药品监督管理局关于同意靶向人类BRAF蛋白V600E突变小分子抑制剂HLX208单药或联合治疗晚期实体瘤开展临床试验的批准。（财联社）

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600196" data-code="600196|1|1" data-code2="600196|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600196&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600196_0" data-code="K 600196|1|1" data-code2="K 600196|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02196" data-code="02196|116|5" data-code2="02196|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02196&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02196_0" data-code="K 02196|116|5" data-code2="K 02196|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p><span id="Info.116.02196"><a href="http://quote.eastmoney.com/unify/r/116.02196" class="keytip" data-code="116,02196">复星医药</a></span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，控股子公司<span id="Info.116.02696"><a href="http://quote.eastmoney.com/unify/r/116.02696" class="keytip" data-code="116,02696">复宏汉霖</a></span>收到国家药品监督管理局关于同意靶向人类BRAF蛋白V600E突变小分子抑制剂HLX208单药或<span id="stock_105.UTHR"><a href="http://quote.eastmoney.com/unify/r/105.UTHR" class="keytip" data-code="105,UTHR">联合治疗</a></span><span id="quote_105.UTHR"></span>晚期实体瘤开展临床试验的批准。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202201182252074418.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)